Advanced Biomedical Research

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 7  |  Issue : 1  |  Page : 126-

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate


Moloud Kazemi, Jaleh Varshosaz, Majid Tabbakhian 
 Department of Pharmaceutics, Novel Drug Delivery Systems Research Center, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

Correspondence Address:
Dr. Jaleh Varshosaz
Department of Pharmaceutics, Novel Drug Delivery Systems Research Centre, Faculty of Pharmacy, Isfahan University of Medical Sciences, Po Box  81745-359, Isfahan
Iran

Background: Many drugs have poor water solubility and so the oral delivery of such drugs is usually associated with limitation of low bioavailability and lack of dose proportionality. Lipid-based liquid crystal (LC) systems are excellent potential formulations for increasing dissolution and bioavailability of drugs. The aim of the present study was to formulate lipid-based LC containing fenofibrate (FFB) as a hydrophobic drug. Materials and Methods: The studied variables included lipid and stabilizer concentrations and the type of stabilizer. The LC formation was identified by the polarized optical microscopic method. The effects of variables on formulation characteristics such as particle size, drug release, and rheological behavior were evaluated. Results: The results showed that the prepared formulations had the particle size between 42 and 503 nm. The drug release profiles showed that FFB had the continuous release from the formulations and the highest dissolution efficiency was seen in formulation prepared by 1.5% of glyceryl monostearate and 0.5% of Pluronic F127 as the stabilizer. The change of stabilizer type from colloidal silica to Pluronic F127 increased the drug release, significantly. Conclusions: In the most formulations of FFB LCs, the DE% was more than the pure drug, and therefore, it seems that the liquid crystalline formulations can be effective for enhancing drug release. Furthermore, drug release rate depended on the stabilizer type so that the presence of colloidal silica caused slower drug release compared to Pluronic F127.


How to cite this article:
Kazemi M, Varshosaz J, Tabbakhian M. Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate.Adv Biomed Res 2018;7:126-126


How to cite this URL:
Kazemi M, Varshosaz J, Tabbakhian M. Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate. Adv Biomed Res [serial online] 2018 [cited 2019 Nov 18 ];7:126-126
Available from: http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=126;epage=126;aulast=Kazemi;type=0